Q2 2026 saw 17% net income growth and 9% adjusted EBITDA growth, with system size and pipeline both up 4% year-over-year. U.S. RevPAR rose 2%, while international RevPAR fell 6%. Full-year guidance was raised, excluding Revo insolvency impacts.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.